The clearance will allow for the Celluma to be used in the treatment of facial wrinkles

BioPhotas, Inc. recently announced the clearance by the FDA (U.S. Food and Drug Administration) of the Celluma, its patented biophotonic medical device, for an additional indication-for-use in treating facial wrinkles. The FDA has previously cleared the Celluma for seven separate indications-for-use, including the treatment of acne, muscle and joint pain, muscle and joint stiffness, muscle spasm, arthritis and compromised local blood circulation.

Commenting on the FDA clearance, Patrick Johnson, President and Chief Executive Officer for BioPhotas said, “The Celluma has really created a new category of Low-Level Light Therapy device, one that combines the power and efficacy of large panel devices and the affordability of small hand-held devices, into a single product that is FDA-cleared to treat the broadest range of muscle, joint and skin conditions on the market. In the Celluma, we have created an extraordinarily versatile product that is effective enough to be used in a professional setting and affordable enough to be used in the home.”

The Celluma uses three discrete wavelengths of light energy simultaneously, modulated with proprietary electronic algorithms, to effectively treat a variety of skin, muscle and joint conditions. The Celluma is distinct from other light therapy devices given its patented flexible design that molds to the body to allow the light to be absorbed more effectively, leading to higher efficacy and more predictable outcomes. In a clinical study reviewed by three board certified dermatologists, the Celluma was shown to have produced a lasting and quantifiable reduction in facial wrinkles 12 weeks after the completion of a 4-week treatment regime.

In support of the new FDA clearance, BioPhotas has announced the launch of a new website, which explains in great detail the health and wellness benefits of Low-Level Light Therapy (LLLT), and specifically of the Celluma. The website highlights the use of the Celluma in treating acne and wrinkles, as well as aches and pain. The scientific foundation for LLLT is presented,from the seminal research conducted by NASA to the research sponsored by BioPhotas at the prestigious Beckman Laser Institute at the University of California, Irvine.

Visit the new website at www.biophotas.com.